U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma

Publisher： Karger

E-ISSN： 1424-859x|119|3-4|204-210

ISSN： 1424-8581

Source： Cytogenetic and Genome Research, Vol.119, Iss.3-4, 2008-02, pp. : 204-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

U-HO1: Eine neue Zelllinie, abstammend von einem primär therapierefraktären klassischen Hodgkin-Lymphom

By Möller P.   Mader A.   Barth T.F.E.   Brüderlein S.  

Der Pathologe, Vol. 29, Iss. 2, 2008-11 ,pp. : 317-318

Springer Publishing Company

Access to resources Recommend Favorite

Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma

By  

Acta Haematologica, Vol. 136, Iss. 3, 2016-09 ,pp. : 186-190

Karger

Access to resources Recommend Favorite

Coexistence of Primary Refractory Anemia with Ringed Sideroblasts and T Cell-Lymphoblastic Non-Hodgkin Lymphoma

By  

Acta Haematologica, Vol. 111, Iss. 3, 2004-03 ,pp. : 171-172

Karger

Access to resources Recommend Favorite

Phase II trial of ofatumumab plus ESHAP (O‐ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first‐line chemotherapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 174, Iss. 6, 2016-09 ,pp. : 859-867

John Wiley & Sons Inc

Access to resources Recommend Favorite

Composite Mantle‐Cell Lymphoma and Classical Hodgkin Lymphoma in a Very Old Adult

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 4, 2015-04 ,pp. : 824-826

John Wiley & Sons Inc

Access to resources Recommend Favorite